Indicated for: dyslipidemia
Route of administration: oral
Substance: ezetimibe + atorvastatin (lipid-lowering agent + statin lipid-lowering agent)
ATC: C10BA05 (Cardiovascular system | Lipid modifying agents, combinations | Combinations of various lipid modifying agents)
Avoid grapefruit and grapefruit juice.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
Seek medical advice if unexplained muscle pain occurs.
Periodic laboratory tests may be required during treatment.
Use during pregnancy only on medical advice.
The combination of ezetimibe and atorvastatin is used to lower total cholesterol and LDL ('bad') cholesterol levels in the blood. Ezetimibe reduces cholesterol absorption in the intestines, while atorvastatin decreases cholesterol production in the liver. Together, these medications help prevent cardiovascular diseases such as heart attack or stroke.
The medication is taken orally as prescribed by the doctor, usually once a day. The dose is adjusted based on blood test results and the patient's cardiovascular risk. It is important for the patient to follow a low-fat diet and maintain a healthy lifestyle during treatment.
Side effects may include muscle pain, increased liver enzyme levels, digestive disorders, or, rarely, severe allergic reactions. In rare cases, serious muscle conditions such as rhabdomyolysis may occur. Any unusual symptoms should be reported to the doctor immediately.
The combination of ezetimibe and atorvastatin is effective in controlling cholesterol levels, but requires regular medical monitoring. Following the doctor's recommendations and being informed about possible side effects are essential for safe and effective treatment.
Price
Copayment
Patient
43.37 RON
6.74 RON
36.63 RON